From mice to men: lessons from mutant ataxic mice. Jan Cendelin, Cerebellum & Ataxias 2014 1:4, doi:10.1186/2053-8871-1-4
OPEN ACCESS
Tuesday, June 17, 2014
Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich’s Ataxia Patient iPSC derived Neural Stem Cells
Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich’s Ataxia Patient iPSC derived Neural Stem Cells. Bing Shan, Chunping Xu, Yaoyang Zhang, Tao Xu, Joel Gottesfeld, and John R. Yates; J. Proteome Res., Just Accepted Manuscript, DOI: 10.1021/pr500514r, Publication Date (Web): June 16, 2014
Subscribe to:
Posts (Atom)
